z-logo
Premium
Cytotoxicity of albebetin oligomers depends on cross‐β‐sheet formation
Author(s) -
Zamotin Vladimir,
Gharibyan Anna,
Gibanova Natalia V.,
Lavrikova Marika A.,
Dolgikh Dmitry A.,
Kirpichnikov Michail P.,
Kostanyan Irina A.,
Morozova-Roche Ludmilla A.
Publication year - 2006
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2006.03.074
Subject(s) - cytotoxicity , thioflavin , monomer , chemistry , fibril , biophysics , amyloid (mycology) , viability assay , biochemistry , amyloid fibril , in vitro , stereochemistry , amyloid β , polymer , organic chemistry , alzheimer's disease , biology , medicine , inorganic chemistry , disease , pathology
Prefibrillar cytotoxicity was suggested as a common amyloid characteristic. We showed two types of albebetin prefibrillar oligomers are formed during incubation at pH 7.3. Initial round‐shaped oligomers consist of 10–15 molecules determined by atomic force microscopy, do not bind thioflavin‐T and do not affect viability of granular neurons and SH‐SY5Y cells. They are converted into ca. 30–40‐mers possessing cross‐β‐sheet and reducing viability of neuronal cells. Neither monomers nor fibrils possess cytotoxicity. We suggest that oligomeric size is important for stabilising cross‐β‐sheet core critical for cytotoxicity. As albebetin was used as a carrier‐protein for drug delivery, examination of amyloidogenicity is required prior polypeptide biomedical applications.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom